Reactive Oxygen Species Induction by Hepatitis B Virus: Implications for Viral Replication in p53-Positive Human Hepatoma Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
15 Jun 2024
Historique:
received: 24 04 2024
revised: 03 06 2024
accepted: 11 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 27 6 2024
Statut: epublish

Résumé

Hepatitis B virus (HBV) infects approximately 300 million people worldwide, causing chronic infections. The HBV X protein (HBx) is crucial for viral replication and induces reactive oxygen species (ROS), leading to cellular damage. This study explores the relationship between HBx-induced ROS, p53 activation, and HBV replication. Using HepG2 and Hep3B cell lines that express the HBV receptor NTCP, we compared ROS generation and HBV replication relative to p53 status. Results indicated that HBV infection significantly increased ROS levels in p53-positive HepG2-NTCP cells compared to p53-deficient Hep3B-NTCP cells. Knockdown of p53 reduced ROS levels and enhanced HBV replication in HepG2-NTCP cells, whereas p53 overexpression increased ROS and inhibited HBV replication in Hep3B-NTCP cells. The ROS scavenger N-acetyl-L-cysteine (NAC) reversed these effects. The study also found that ROS-induced degradation of the HBx is mediated by the E3 ligase Siah-1, which is activated by p53. Mutations in p53 or inhibition of its transcriptional activity prevented ROS-mediated HBx degradation and HBV inhibition. These findings reveal a p53-dependent negative feedback loop where HBx-induced ROS increases p53 levels, leading to Siah-1-mediated HBx degradation and HBV replication inhibition. This study offers insights into the molecular mechanisms of HBV replication and identifies potential therapeutic targets involving ROS and p53 pathways.

Identifiants

pubmed: 38928309
pii: ijms25126606
doi: 10.3390/ijms25126606
pii:
doi:

Substances chimiques

Tumor Suppressor Protein p53 0
Reactive Oxygen Species 0
Trans-Activators 0
hepatitis B virus X protein 0
Viral Regulatory and Accessory Proteins 0
Ubiquitin-Protein Ligases EC 2.3.2.27
seven in absentia proteins EC 2.3.2.27
Nuclear Proteins 0
TP53 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Pusan National University
ID : two-year Research Grant

Auteurs

Yuna Jeong (Y)

Department of Integrated Biological Science, The Graduate School, Pusan National University, Busan 46241, Republic of Korea.

Jiwoo Han (J)

Department of Integrated Biological Science, The Graduate School, Pusan National University, Busan 46241, Republic of Korea.

Kyung Lib Jang (KL)

Department of Integrated Biological Science, The Graduate School, Pusan National University, Busan 46241, Republic of Korea.
Department of Microbiology, College of Natural Science, Pusan National University, Busan 46241, Republic of Korea.
Microbiological Resource Research Institute, Pusan National University, Busan 46241, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH